Lupin Limited’s plans for a US generic to GlaxoSmithKline plc’s blockbuster Advair Diskus (fluticasone propionate/salmeterol) are coming undone as a 2015 partnership with the Polish company Celon Pharma SA to jointly develop the dry powder inhaler (DPI) product is close to being terminated.
An industry source told Scrip the deal was nearing its end, while a Lupin spokesperson declined to comment when contacted....





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
